欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil succinate	EMEA/H/C/004274	KRKA, d.d., Novo mesto	2018/02/08	Authorised
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil maleate	EMEA/H/C/004240	Mylan Pharmaceuticals Limited	2017/09/05	Authorised
Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil phosphate	EMEA/H/C/004250	Zentiva k.s.	2017/07/17	Authorised
Efavirenz Teva	Human	efavirenz	efavirenz	EMEA/H/C/002352	Teva B.V.	2012/01/09	Authorised
Atripla	Human	efavirenz;emtricitabine;tenofovir disoproxil	efavirenz;emtricitabine;tenofovir disoproxil fumarate	EMEA/H/C/000797	Gilead Sciences Ireland UC	2007/12/13	Withdrawn
Sustiva	Human	efavirenz	efavirenz	EMEA/H/C/000249	Bristol-Myers Squibb Pharma EEIG	1999/05/28	Withdrawn
Stocrin	Human	efavirenz	efavirenz	EMEA/H/C/000250	Merck Sharp & Dohme B.V.	1999/05/28	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-